cipamfylline has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alenius, H; Kemp, K; Kvist, PH; Lauerma, A; Lehto, M; Savinko, T; Wolff, H | 1 |
| Badger, AM; Esser, KM; Olivera, DL | 1 |
2 other study(ies) available for cipamfylline and Disease Models, Animal
| Article | Year |
|---|---|
A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Betamethasone Valerate; Calcineurin Inhibitors; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Enterotoxins; Female; Immunoglobulin A; Immunoglobulin E; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphodiesterase Inhibitors; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Skin; Tacrolimus; Xanthines | 2010 |
Beneficial effects of the phosphodiesterase inhibitors BRL 61063, pentoxifylline, and rolipram in a murine model of endotoxin shock.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrrolidinones; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha; Xanthines | 1994 |